| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | SVP, Chief Business Officer
2 companies
Gros David-Alexandre C is a Chief Executive Officer at ELDN, with reported holdings spanning 2 companies. Recent filings cover 5 purchases and 0 sales. Those positions are worth an estimated $63K at current prices.
Our model assigns Gros David-Alexandre C a below-average insider score of 18/100, based on 3 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -50.8%.
Gros David-Alexandre C's largest disclosed position is in ALNY as SVP, Chief Business Officer, worth about $63K. Net of sales, the recent Form 4 record there shows accumulation of 1,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | ELDN Eledon Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 2,000 | $4.48 | $8,960.00 | +28.6% | -22.9% | -46.5% | |
| Aug 17, 2021 | ELDN Eledon Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 4,000 | $6.21 | $24,840.00 | +133.3% | -13.1% | -47.7% | |
| Jun 9, 2021 | ELDN Eledon Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 3,000 | $8.01 | $24,030.00 | New | -0.7% | -58.1% | |
| Feb 22, 2016 | ALNY Alnylam Pharmaceuticals, Inc. | SVP, Chief Business Officer | Buy | 1,000 | $62.75 | $62,749.00 | New | - | - |